Recently, GSG2 have been reported to act as a cancer-promoting factor in various human tumors (Huertas et al. 2012), such as prostate cancer (Yu et al. 2020), gallbladder cancer (Zhu et al. 2020), and pancreatic cancer (Han et al. 2019). Here, HASPIN is linked to prostate cancer.